AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Discounted Cash Flow (DCF) Analysis Unlevered

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

36.11 4.01 Healthcare
All | Operating Data | Balance Sheet Data | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results

Operating Data IFRX Quote InflaRx N.V

Balance Sheet Data IFRX Quote InflaRx N.V

Weighted Average Cost Of Capital IFRX Quote InflaRx N.V

Share Price $ 36.11
Diluted Shares Outstanding 0
Cost of Debt
Tax Rate -
After-tax Cost of Debt -
Risk Free Rate
Market Risk Premium
Cost of Equity 2.18
Total Debt 0.00
Total Equity 830.53
Total Capital 830.53
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash IFRX Quote InflaRx N.V

Terminal Value IFRX Quote InflaRx N.V

Growth in perpetuity method:
Long term growth rate
WACC (%) 2.2
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value IFRX Quote InflaRx N.V

Enterprise Value -
Net Debt -29
Equity Value -
Shares Outstanding 23
Equity Value Per Share -

Results Unlevered DCF IFRX Quote InflaRx N.V